ACTRN12608000498392已完成4 期
The role of glucoregulatory processes in the cognition-enhancing effects of selected botanicals in healthy adults
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 入组人数
- 160
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Prevention
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 18 Years 至 40 Years（—）
- 性别
- All
入选标准
- •non-smoker,
- •no history of anxiety, depression or psychiatric disorders
- •not taking medication (prescription or over the counter), herbal extracts, vitamin supplements or illicit drugs
- •no kidney disease, liver disease and/or gastrointestinal diseases (e.g. Irritable bowel syndrome, celiac disease, peptic ulcers)
- •no health conditions affecting blood glucose levels - Diabetes (Type 1 & 2), hypoglycaemia, hyperglycaemia
- •no health conditions affecting the adrenal glands - Cushing's disease, Addison's disease
- •not pregnant or breast feeding.
排除标准
- •history of anxiety, depression or psychiatric disorders
- •taking any medication (prescription or over the counter), herbal extracts, vitamin supplements or illicit drugs
- •food allergies, kidney disease, liver disease and/or gastrointestinal diseases (e.g. Irritable bowel syndrome, celiac disease, peptic ulcers)
- •health conditions affecting blood glucose levels - Diabetes (Type 1 & 2), hypoglycaemia, hyperglycaemia
- •health conditions affecting the adrenal glands - Cushing's disease, Addison's disease
- •pregnant or breast feeding.
研究者
相似试验
招募中
不适用
Investigation of glucose metabolism and neural substrates in patients with schizophrenia and mood disorder with ECTSchizophrenia, mood disorderJPRN-UMIN000013877Department of Psychiatry, Graduate School of Medicine, Kyoto University90
已完成
不适用
The changes in blood glucose during weights exercise in individuals with type 1 diabetes, with a view to improve exercise-associated fluctuations in blood glucoseNutritional, Metabolic, EndocrineInsulin-dependent diabetes mellitusType 1 diabetesISRCTN60407046Swansea University (UK)12
进行中（未招募）
不适用
Evaluation of potential central glucoregulatory compounds to treat/ameliorate the symptoms of schizophrenia: a proof-of-concept study in healthy volunteers - EICASBasic ressearch on schizophrenia. This is a proof-of-concept trial. The hypothesis is that substances that regulate the central glucose utilisation might ameliorate symptoms of schizophrenic psychosis. In this clinical trial healthy volunteers will take one of these substances or placebo for seven days and will extensively tested for within and after the administration.MedDRA version: 9.1Level: LLTClassification code 10039626Term: SchizophreniaEUCTR2007-002245-20-DEZentralinstitut für Seelische Gesundheit Mannheim
撤回
1 期
Evaluation Study of New Compounds with Potential Use in SchizophreniaSchizophreniaNCT00916201Central Institute of Mental Health, Mannheim86
已完成
不适用
Glucose and Fructose Stimulated Brain Activity in Obese Subjects Before and After Bariatric SurgeryExploratory BehaviorNCT02902224University Hospital, Basel, Switzerland15